Revolution or mirage? Controversy surrounds new Alzheimer’s drugs

Two new drugs, the first capable of slowing down the debilitating progression of Alzheimer’s disease, have become embroiled in one of the biggest medical controversies in recent years.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup